» Articles » PMID: 34050678

Prenatal Histological, Cellular, and Molecular Anomalies in Trisomy 21 Lung

Overview
Journal J Pathol
Specialty Pathology
Date 2021 May 29
PMID 34050678
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Down syndrome (DS), also known as trisomy 21 (T21), is the most common human chromosomal anomaly. Although DS can affect many organ systems, lung and heart disease are the leading causes of death. An abundance of existing data suggests that lung abnormalities originate postnatally in DS. However, a single report of branching insufficiency in DS has inferred a potential prenatal origin. The histology of T21 fetal lungs (n = 15) was assessed by an experienced pathologist. Spatial differences in cellular phenotypes were examined using immunohistochemistry (IHC). Comprehensive gene expression in prenatal T21 lungs (n = 19), and age-matched controls (n = 19), was performed using high-throughput RNA sequencing (RNAseq) and validated by RT-qPCR. Histopathological abnormalities were observed in approximately half of T21 prenatal lung samples analyzed, which included dilated terminal airways/acinar tubules, dilated lymphatics, and arterial wall thickening. IHC for Ki67 revealed significant reductions in epithelial and mesenchymal cell proliferation, predominantly in tissues displaying pathology. IHC demonstrated that airway smooth muscle was reduced and discontinuous in the proximal airway in conjunction with reduced SOX2. RNAseq identified 118 genes significantly dysregulated (FDR < 0.05) in T21 lung when unadjusted and 316 genes when adjusted for age. Ontology analysis showed that IFN pathway genes were appreciably upregulated, whereas complement and coagulation cascades and extracellular matrix pathway genes were downregulated. RT-qPCR confirmed the changes in genes associated with these pathways in prenatal T21 lungs. Our data demonstrate that specific histological, cellular, and molecular abnormalities occur prenatally in different compartments of human T21 lung, which could be representative of premature stage progression. © 2021 The Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Citing Articles

Total cell N-glycosylation is altered during differentiation of induced pluripotent stem cells to neural stem cells and is disturbed by trisomy 21.

Cindric A, Vuckovic F, Murray A, Klaric T, Alic I, Kristic J BBA Adv. 2025; 7():100137.

PMID: 39845703 PMC: 11751427. DOI: 10.1016/j.bbadva.2024.100137.


Interstitial lung disease in the newborn.

Giunta-Stibb H, Hackett B J Perinatol. 2024; 45(1):13-23.

PMID: 38956315 DOI: 10.1038/s41372-024-02036-9.


Emerging role of cellular senescence in normal lung development and perinatal lung injury.

Dennery P, Yao H Chin Med J Pulm Crit Care Med. 2024; 2(1):10-16.

PMID: 38567372 PMC: 10987039. DOI: 10.1016/j.pccm.2024.01.001.


Gene Expression Studies in Down Syndrome: What Do They Tell Us about Disease Phenotypes?.

Chapman L, Ramnarine I, Zemke D, Majid A, Bell S Int J Mol Sci. 2024; 25(5).

PMID: 38474215 PMC: 10932069. DOI: 10.3390/ijms25052968.


A Multimodal Imaging-Supported Down Syndrome Mouse Model of RSV Infection.

Tielemans B, De Herdt L, Pollenus E, Vanhulle E, Seldeslachts L, Marain F Viruses. 2023; 15(4).

PMID: 37112973 PMC: 10144178. DOI: 10.3390/v15040993.


References
1.
Danopoulos S, Alonso I, Thornton M, Grubbs B, Bellusci S, Warburton D . Human lung branching morphogenesis is orchestrated by the spatiotemporal distribution of ACTA2, SOX2, and SOX9. Am J Physiol Lung Cell Mol Physiol. 2017; 314(1):L144-L149. PMC: 8312513. DOI: 10.1152/ajplung.00379.2017. View

2.
Abler L, Mansour S, Sun X . Conditional gene inactivation reveals roles for Fgf10 and Fgfr2 in establishing a normal pattern of epithelial branching in the mouse lung. Dev Dyn. 2009; 238(8):1999-2013. PMC: 3538083. DOI: 10.1002/dvdy.22032. View

3.
Davidson M . Primary care for children and adolescents with Down syndrome. Pediatr Clin North Am. 2008; 55(5):1099-111, xi. DOI: 10.1016/j.pcl.2008.07.001. View

4.
Mitwalli M, Wahba Y, Shaltout A, Gouida M . Lymphocyte subgroups and recurrent infections in children with Down syndrome - a prospective case control study. Cent Eur J Immunol. 2018; 43(3):248-254. PMC: 6305610. DOI: 10.5114/ceji.2018.80042. View

5.
Colvin K, Yeager M . What people with Down Syndrome can teach us about cardiopulmonary disease. Eur Respir Rev. 2017; 26(143). PMC: 9489111. DOI: 10.1183/16000617.0098-2016. View